Trial intelligence / Profile preview

Evaluation of Cardiac Function in COPD Patients After Symbicort

NCT01760304Phase 4Terminated

Sponsor
Brigham and Women's Hospital
Start
Jan 2012
Primary completion
Jul 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of budesonide + formoterol in chronic obstructive pulmonary disease (COPD), sponsored by Brigham and Women's Hospital. Started Jan 2012; status: terminated.

02

Drugs

budesonide + formoterol
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT01760304.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01760304.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call